Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push…
JetBlue Airways is getting ready to announce a partnership with another U.S. airline with a larger network in the coming…
“60 Minutes” correspondent Scott Pelley paid tribute Sunday to Bill Owens, the show’s executive producer who resigned last week, saying…
International Business Machines Corporation on Monday announced it will invest $150 billion in the U.S. over the next five years,…
OKLAHOMA CITY — Amazon and Nvidia executives said Thursday that the construction of artificial intelligence data centers is not…
OKLAHOMA CITY — Amazon and Nvidia executives said Thursday that the construction of artificial intelligence data centers is not…
If President Donald Trump’s 145% levy against imports from China holds, Hasbro estimates it could see as much as a $300…
U.S. spirit exports reached a record $2.4 billion in 2024, driven in large part by tariff concerns and ongoing…